Hayase N, Tomiyoshi K, Watanabe K, Horikoshi S, Shibasaki T, Ohye C
Department of Neurosurgery and Nuclear Medicine, Gunma University School of Medicine, Japan.
Ann Nucl Med. 1995 Aug;9(3):119-23. doi: 10.1007/BF03165037.
PET imaging studies with 4-[18F]fluoro-L-m-tyrosine (FMT) in normal macaca monkeys showed selective accumulations of radioactivity in the striatum with time. In monkeys rendered hemiparkinsonian by intracarotid infusion of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), FMT uptake was eliminated in the lesioned striatum. FMT-PET studies were able to detect dopaminergic terminals in both normal and hemiparkinsonian monkeys, and clearly showed a reduction in aromatic L-amino acid decarboxylase (AAAD) activities in the MPTP-lesioned striatum. These results show that FMT is promising as a PET tracer for the evaluation of central dopaminergic systems in parkinsonism.
在正常猕猴中使用4-[18F]氟-L-间酪氨酸(FMT)进行的PET成像研究显示,随着时间推移,纹状体中有放射性的选择性聚集。在用颈内动脉注射1-甲基-4-苯基-1,2,3,6-四氢吡啶(MPTP)使猕猴患半侧帕金森病的情况下,病变纹状体中FMT摄取消失。FMT-PET研究能够在正常和患半侧帕金森病的猕猴中检测到多巴胺能终末,并清楚地显示出MPTP损伤的纹状体中芳香族L-氨基酸脱羧酶(AAAD)活性降低。这些结果表明,FMT作为一种PET示踪剂,在评估帕金森病中枢多巴胺能系统方面具有前景。